Astellas Pharma, Inc. (ALPMY)
14.32
-0.12
(-0.83%)
USD |
OTCM |
Oct 02, 16:00
Astellas Pharma Gross Profit Margin (Quarterly) : 75.29% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 75.29% |
| March 31, 2026 | 75.94% |
| December 31, 2025 | 73.89% |
| September 30, 2025 | 73.63% |
| June 30, 2025 | 74.77% |
| March 31, 2025 | 76.18% |
| December 31, 2024 | 74.20% |
| September 30, 2024 | 74.72% |
| June 30, 2024 | 73.34% |
| March 31, 2024 | 74.46% |
| December 31, 2023 | 74.32% |
| September 30, 2023 | 74.74% |
| June 30, 2023 | 79.20% |
| March 31, 2023 | 79.80% |
| December 31, 2022 | 79.21% |
| September 30, 2022 | 81.07% |
| June 30, 2022 | 73.91% |
| March 31, 2022 | 77.97% |
| December 31, 2021 | 77.33% |
| September 30, 2021 | 78.83% |
| June 30, 2021 | 79.09% |
| March 31, 2021 | 79.00% |
| December 31, 2020 | 77.28% |
| September 30, 2020 | 78.74% |
| June 30, 2020 | 78.66% |
| Date | Value |
|---|---|
| March 31, 2020 | 80.52% |
| December 31, 2019 | 74.26% |
| September 30, 2019 | 78.39% |
| June 30, 2019 | 76.75% |
| March 31, 2019 | 75.75% |
| December 31, 2018 | 74.02% |
| September 30, 2018 | 74.39% |
| June 30, 2018 | 75.76% |
| March 31, 2018 | 78.67% |
| December 31, 2017 | 72.43% |
| September 30, 2017 | 75.25% |
| June 30, 2017 | 72.64% |
| March 31, 2017 | 74.24% |
| December 31, 2016 | 67.90% |
| September 30, 2016 | 73.41% |
| June 30, 2016 | 76.18% |
| March 31, 2016 | 75.79% |
| December 31, 2015 | 70.03% |
| September 30, 2015 | 74.02% |
| June 30, 2015 | 70.62% |
| March 31, 2015 | 71.35% |
| December 31, 2014 | 69.17% |
| September 30, 2014 | 69.20% |
| June 30, 2014 | 71.25% |
| December 31, 2013 | 68.72% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Takeda Pharmaceutical Co., Ltd. | 57.57% |
| Daiichi Sankyo Co., Ltd. | 78.37% |
| Ono Pharmaceutical Co., Ltd. | 75.31% |
| Eisai Co., Ltd. | 78.20% |
| Chugai Pharmaceutical Co., Ltd. | 69.49% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 21.07% |
| Return on Assets | 10.28% |
| Return on Invested Capital | 14.81% |
| Profit Margin (Quarterly) | 22.12% |
| Operating Margin (Quarterly) | 28.98% |
| Return on Net Operating Assets | 12.63% |